Today, Symbiotic is the No. 2 brand and not Suprimox. In tomorrow's market place if Cipla does not respond, it will lose its share and the number one position which it enjoys. Introduction of Novaclox - L needs to be watched. Pace is an important essence of success for any marketing company. However, with introduction of Symbiotic the market is changing.
Many new products are new in the market.
High growth rate added with positive response to Symbiotic can give a threat. Introduction of Novaclox - L has halted the decline and should help to the brand to climb the ladder still father. Introduction of tablet should also help Novaclox to consolidate its position. Delay will lead to erosion in their leadership position.